Apart from certain ACE2 genetic variants, insertion–deletion polymorphism in ACE (ACE I/D) may also modulate COVID-19 disease severity by elevating physiological Ang II concentration [14,15] such that the DD genotype of ACE I/D polymorphism increases the risk of COVID-19 severity [16]. The gene discussed is ACE2; the disease is COVID-19.